Balance Labs Inc

For the period ended Dec 31, 2023. Filed Apr 15, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Apr 15, 2024

BLNCStored price and day change unavailable

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

SIGNATURES

Pursuant to the requirement of Section 13 or 15(d) of the Securities Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on the 15 th of April, 2024.

BALANCE LABS, INC.
By:	/s/ Michael D. Farkas
	Michael D. Farkas
	President, Chief Executive Officer and Chairman of the Board
	(Principal Executive Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Carmen Villegas
Signature	Title	Date
/s/ Michael D. Farkas	President, Chief Executive Officer	April 15, 2024
Michael D. Farkas	and Chairman of the Board
	(Principal Executive Officer and Principal Financial Officer)
/s/ Ari Feldman	Chief Financial Officer	April 15, 2024
Ari Feldman	(Principal Financial Officer)
/s/ Carmen Villegas	Secretary and Director	April 15, 2024

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.